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Abstract
Objective
Multidimensional computerized adaptive testing enables precise measurements of patient-
reported outcomes at an individual level across different dimensions. This study examined
the construct validity of a multidimensional computerized adaptive test (CAT) for fatigue in
rheumatoid arthritis (RA).
Methods
The ‘CAT Fatigue RA’ was constructed based on a previously calibrated item bank. It con-
tains 196 items and three dimensions: ‘severity’, ‘impact’ and ‘variability’ of fatigue. The
CAT was administered to 166 patients with RA. They also completed a traditional, multidi-
mensional fatigue questionnaire (BRAF-MDQ) and the SF-36 in order to examine the CAT’s
construct validity. A priori criterion for construct validity was that 75% of the correlations
between the CAT dimensions and the subscales of the other questionnaires were as
expected. Furthermore, comprehensive use of the item bank, measurement precision and
score distribution were investigated.
Results
The a priori criterion for construct validity was supported for two of the three CAT dimen-
sions (severity and impact but not for variability). For severity and impact, 87% of the corre-
lations with the subscales of the well-established questionnaires were as expected but for
variability, 53% of the hypothesised relations were found. Eighty-nine percent of the items
were selected between one and 137 times for CAT administrations. Measurement precision
was excellent for the severity and impact dimensions, with more than 90% of the CAT
administrations reaching a standard error below 0.32. The variability dimension showed
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good measurement precision with 90% of the CAT administrations reaching a standard
error below 0.44. No floor- or ceiling-effects were found for the three dimensions.
Conclusion
The CAT Fatigue RA showed good construct validity and excellent measurement precision
on the dimensions severity and impact. The dimension variability had less ideal measure-
ment characteristics, pointing to the need to recalibrate the CAT item bank with a two-
dimensional model, solely consisting of severity and impact.
Introduction
Many patients with rheumatoid arthritis (RA) experience fatigue [1, 2] and describe it as a mul-
tidimensional experience [3–6] and an annoying symptom with far-reaching consequences for
daily life [7, 8]. Nevertheless, most questionnaires for fatigue in RA are unidimensional and
were not developed from the patients’ perspective [9, 10]. Patients’ experience is necessary to
gain insight into their subjective symptoms and to develop content valid items [11–13]. Our
aim was to improve the measurement of fatigue in RA by incorporating the perspective of
patients and by using modern psychometrics. To achieve this goal, we developed a multidimen-
sional computerized adaptive test–the ‘CAT Fatigue RA’.
In a computerized adaptive test (CAT), the computer automatically selects items from a
large item bank and subsequently selects the next question based on the previous answer
entered by the person completing the CAT. In contrast to traditional questionnaires, CAT
measurements for fatigue are more precise since the CAT increasingly discriminates and asks
questions based on individuals’ answers regarding their level of fatigue [14]. For the computer-
ized selection of the best matching items, an item pool has to be scaled according to item
response theory (IRT). With IRT, item parameters can be assessed for each item independently
so that it is known which level of fatigue is represented by the items. This information is
required to ideally match the items to the patient’s individual level and for inter-individual
comparisons even when patients complete different items [14].
We previously published the development of our item pool and its calibration with IRT. To
summarize these studies, first, the fatigue experience of patients was investigated [6, 15]. Then,
a large item pool was developed. It contained items of existing questionnaires and new items
that had been constructed based on our interview material. This item pool was evaluated by
patients and professionals in a Delphi study [9, 16, 17] and finally calibrated with multidimen-
sional IRT [18]. Based on the results of the calibration, the multidimensional CAT Fatigue RA
was constructed. It contains 196 items in three dimensions: ‘severity’, ‘impact’ and ‘variability’
of fatigue. According to our knowledge, this is the first CAT that has been developed from the
perspective of patients with RA. Another novelty is its multidimensionality. Most of the exist-
ing CATs are unidimensional or based on two separately calibrated item banks [19–21]. For
example within the PROMIS initiative, two fatigue item banks (experience and impact) have
been developed for computerized adaptive testing in the general population and different
chronic conditions [21]. If factor analysis and theories based on clinical experience clearly
point to multidimensionality, multidimensional IRT models should be applied, despite their
being far more complex than unidimensional IRT models [22]. The multidimensionality of
fatigue in RA was raised by patients [3–6] but also supported by statistical techniques, and the
best possible IRT model was three-dimensional [18]. Multidimensional computerized adaptive
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testing (MCAT) is fairly new [23], but studies have demonstrated that it can lead to precise and
efficient measurements of health outcomes [24, 25]. The cross-information provided by items
of correlated dimensions facilitates selection of the most informative items, leading to equal or
even higher precision with approximately one-third fewer items than would be needed in uni-
dimensional adaptive testing [26].
The objective of this study was to examine the construct validity of our CAT Fatigue RA.
Moreover, the comprehensive use of items of the item bank, measurement precision and the
distribution of scores were investigated. These aspects provide specific information about
interpretability, reliability and validity of the CAT Fatigue RA, which are important measure-
ment properties for the evaluation of health-related patient-reported outcomes (HR-PRO)
[27, 28].
Materials and Methods
Patients
Consecutive outpatients with RA from five hospitals in The Netherlands were recruited
between the beginning of September and the beginning of December 2013 via the web system
ROMA (Rheumatology Online Monitor Application). This system is currently used at the
Arthritis Centre Twente and other hospitals of the Dutch Rheumatoid Arthritis Monitoring
(DREAM) collaboration [29]. Upon logging into the web system, patients with RA were invited
to participate. Once they agreed, the patients were automatically led via the website to the ques-
tionnaires belonging to the study. We did not apply any exclusion criteria such as the presence
of co-morbidity or a certain disease duration since it was intended to include a representative
sample of outpatients with RA. The ethical committee of the University of Twente approved
the study.
Measures
CAT Fatigue RA. The multidimensional CAT Fatigue RA measures fatigue on three
dimensions [18]. The dimension ‘severity’ contains 13 items about severity, duration, and fre-
quency. The dimension ‘impact’ consists of 169 items about the following topics: cognition/
concentration, negative emotions/mood, energy, sleep/rest, body feeling, coping and conse-
quences. The dimension ‘variability’ has 14 items about changes in fatigue and perceived
causes. The level of fatigue is expressed in theta values. Theta values are the usual unity in IRT
and CAT for the estimation of the construct under consideration, and values are expressed on
a metric with a mean of zero and a standard deviation of 1 [22]. Higher thetas indicate higher
fatigue levels.
The basis for the construction of the CAT Fatigue RA was the previously calibrated item
bank [18]. A between-items multidimensional IRT model was applied, whereby it was assumed
that the item bank pertained to a limited number of correlated latent dimensions and that
every item loaded in one dimension only. The algorithm of the CAT was based on research on
multidimensional adaptive testing by Segall [26]. Therefore, item selection follows Bayesian
principles; that is, the item that has the greatest potential to reduce the statistical uncertainty
about the fatigue level of the patient is selected from the potential items in the bank [26].
The CAT algorithm was implemented in ROMA. To determine start- and stopping-rules,
simulations of the CAT administration were conducted with about 1000 virtual patients. The
optimal measurement precision on the three fatigue dimensions was reached with the follow-
ing characteristics: two random start items per dimension, at least five items per dimension,
and a total number of 20 administered items in the CAT. To ensure that the transformation of
the CAT algorithm to ROMA was correct, we conducted several test calculations and checked
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whether both algorithms provided the same fatigue estimates. The criterion of 100% confor-
mity was reached.
Based on the results of a usability test [30], a brief text was included before the start of the
CAT to inform patients that some items might appear similar. Moreover, the response option
‘not applicable’ was added to six items of the impact dimension (e.g. items about the impact of
fatigue on work). If a patient chooses this option, the CAT selects, as a substitute, the second
optimal item for that particular patient at that point in the test.
BRAF-MDQ and BRAF-NRS. The Bristol Rheumatoid Arthritis Fatigue Multi-Dimen-
sional Questionnaire (BRAF-MDQ) was developed in the UK [10] and officially translated into
Dutch [31]. The BRAF-MDQ contains 20 items and measures four dimensions: physical
fatigue, living with fatigue, cognition and emotion. Sum scores can be calculated for each
dimension separately. Besides the BRAF-MDQ, patients in our study also filled in the three
Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF-NRSs). These eleven-
point NRSs measure fatigue severity, effect and coping. Higher scores on the NRS about fatigue
severity and effect have a negative meaning while a higher score on the NRS about coping with
fatigue indicates a positive outcome (better coping). The BRAF-MDQ showed good internal
consistency and, along with the BRAF-NRSs, good criterion validity, construct validity and
sensitivity to change [10, 32]. Only the BRAF-NRS coping was not sensitive to change in a
pharmacological intervention, suggesting that coping with fatigue is a concept different from
severity and effect and should be assessed separately [32].
MOS 36-item short-form health survey (SF-36). The SF-36 [33] contains eight subscales:
physical functioning, role limitations because of physical health problems, bodily pain, social
functioning, mental health, role limitations because of emotional problems, vitality, and gen-
eral health perceptions. Standardized scores from 0–100 were calculated, whereby lower scores
indicate poorer health- related quality of life (HRQoL). The SF-36 is an adequate instrument to
measure health status in Dutch patients with RA [34].
Analyses
The data used for the following analyses are available as online supporting files.
Construct validity. To examine construct validity correlations between the CAT Fatigue
RA and the BRAF-MDQ, the BRAF-NRS and SF-36 were calculated.
We expected high correlations (r .60) between the scores on the dimensions of the CAT
and the dimensions of the BRAF-MDQ, the BRAF-NRS scales for severity and effect of fatigue,
and the SF-36 subscale vitality (Table 1). All of these dimensions are validated measurements
of fatigue. Furthermore, we expected a moderate association between the CAT dimensions and
the other subscales of the SF-36 (r> .30 and< .60) and the BRAF-NRS coping. The constructs
measured by those SF-36 subscales (e.g. pain, mental health) are closely related to, but different
from fatigue [35]. Also, according to Dures et al. [32], the BRAF-NRS coping with fatigue is
assumed to measure a concept different from severity and effect.
Table 1. Hypothesised strength of correlations with CAT severity, impact and variability.
Expected strength of
correlations
High (r  .60) BRAF-MDQ physical, living, emotion, cognition, BRAF-NRS severity, effect,
SF-36 vitality
Moderate (r > .30 and < .60) SF-36 physical functioning, role limitations because of physical health
problems, bodily pain, social functioning, mental health, general health
perceptions, role limitations because of emotional problems, BRAF-NRS
coping
doi:10.1371/journal.pone.0145008.t001
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As generally recommended for large-scale surveys [36], plausible values were used to esti-
mate the correlations of the other variables with the CAT scores because the latter are estimates
with estimation errors rather than directly observed variables. We applied the a priori criterion
for construct validity such that at least 75% of the specified hypotheses needed to be supported
by the analyses [37].
Comprehensive use of items of the item bank. We checked the frequency of use of each
item to find out which proportion of items from the item pool had been selected. The dimen-
sions severity and variability contained far less items than the impact dimension, consequently,
severity and variability items had a lower chance to be selected than impact items. Moreover, at
least five items per dimension were provided to each patient according to the administration
rules.
Measurement precision. We expected excellent measurement precision (mean SE 0.32)
for the dimensions severity and impact and lower but adequate measurement precision for var-
iability. This hypothesis was based on previous research [38], whereby the standard error (SE)
on the dimension severity and impact always reached a level of 0.32 before the end of the
CAT administration of 20 items. This SE is equivalent to a reliability of r = 0.90, which indi-
cates excellent reliability of a CAT [39, 40]. The SE of the dimension variability was larger, but
even the largest final SE of this dimension was still equivalent to r = 0.81, reflecting good reli-
ability [39, 12]. The SEs of the fatigue scores (theta values) per dimension were assessed per
patient. Subsequently, the mean SE, its standard deviation, minimum and maximum values
and values on the percentiles were calculated for each of the three dimensions. The criterion of
0.32 for excellent reliability can be applied to each of the CAT Fatigue RA dimensions sepa-
rately. This is because the theta-distribution on each dimension has a standard deviation of 1,
so the SE of 0.32 entails a proportion of true variance of 0.90, analogous to the unidimensional
case.
Score distribution. We assumed minimal floor- and ceiling-effects due to the adaptive
selection mechanism of a CAT. To examine floor- and ceiling-effects, the distribution of theta
scores in the sample were described and graphically displayed. When more than 15% of the
CAT administrations led to the highest or lowest possible score, floor- or ceiling-effects were
considered present [37].
For the calculation of the correlations needed for the construct validation, a sample size of
at least 123 participants is required to detect a significant correlation of .25 with a statistical
power of (1-beta) = .80 in a two-tailed test with an alpha of 0.05. This sample size is also ade-
quate for the other analyses.
Results
In total, 166 patients participated in this study. Their mean scores on the CAT are displayed in
Table 2, and their mean scores on the other instruments are displayed in Table 3.
The sample consisted of 72 men and 94 women, diagnosed with RA and with a mean age of
57.64 years (SD = 10.60; range: 23–83 years) and a mean disease duration of 9.42 years
(SD = 10.17; range: 0–69 years).
Construct validity
In conformity with our hypotheses, high correlations (r .60) were found between the scores
on the severity and impact dimensions of the CAT and all dimensions of the BRAF-MDQ, the
BRAF-NRS for severity and effect of fatigue, and the SF-36 subscale vitality (Table 4). The
hypotheses regarding the association between those scales and the CAT variability dimension
could only be supported for the BRAF physical dimension. All other correlations were lower
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than expected. However, they were still moderate, ranging between 0.39 (BRAF emotion) and
0.56 (BRAF-NRS severity).
As expected, most of the associations between the CAT dimensions and the SF-36 subscales
and the BRAF-NRS coping were moderate (r> .30 and< .60). Exceptions were slightly higher
correlations between the SF-36 subscale role limitations because of physical health problems
and the CAT dimensions severity (.60) and impact (.62), and the SF-36 subscale social func-
tioning and the CAT impact dimension (.61). Moreover, the association between the CAT
severity and variability dimensions and the BRAF-NRS coping were slightly lower than
expected (0.30 and 0.20).
With 87% of the hypotheses supported (Table 4), the construct validity of the dimensions
severity and impact of the CAT Fatigue RA was confirmed. Regarding the dimension variabil-
ity, 53% of the correlations were as expected.
Comprehensive use of items of the item bank
Table 5 provides an overview of the frequency of item usage during the 166 CAT administrations.
Table 2. Theta-scores per CAT dimension.
CAT severity CAT impact CAT variability
Mean theta score -0.18 -0.22 -0.33
Standard deviation 1.32 1.25 0.88
Minimum -3.06 -3.50 -2.87
Maximum 2.66 2.50 1.54
Percentiles
25 -0.94 -0.87 -0.72
50 -0.12 -0.00 -0.19
75 0.81 0.63 0.23
Number (percentage) of scores above 2 8 (4.8%) 2 (1.2%) 0 (0%)
Number (percentage) of scores below 2 18 (10.8%) 18 (10.8%) 13 (7.8%)
Theta scores have a mean of 0 and SD of 1, higher scores indicate higher fatigue.
doi:10.1371/journal.pone.0145008.t002
Table 3. Sample means on BRAF-MDQ (N = 164), BRAF-NRS (N = 165) and SF-36 (N = 165).
Measure Mean (minimum score–maximum score) Standard deviation
BRAF-MDQ physical 10.59 (0–21) 5.85
BRAF-MDQ living 4.37 (0–21) 4.00
BRAF-MDQ emotion 1.95 (0–9) 2.38
BRAF-MDQ cognition 2.79 (0–15) 2.97
BRAF-NRS severity 4.31 (0–9) 2.54
BRAF-NRS effect 4.02 (0–10) 2.66
BRAF-NRS coping 6.61 (0–10) 2.32
SF-36 Physical Functioning (PF) 65.76 (5–100) 24.54
SF-36 Role Physical (RP) 57.01 (0–100) 26.00
SF-36 Bodily Pain (BP) 61.38 (12–100) 19.24
SF-36 General Health (GH) 54.83 (5–97) 18.90
SF-36 Vitality (VT) 55.95 (0–100) 19.67
SF-36 Social Functioning (SF) 77.80 (0–100) 22.14
SF-36 Role Emotional (RE) 75.10 (0–100) 26.26
SF-36 Mental Health (MH) 75.36 (25–100) 17.07
doi:10.1371/journal.pone.0145008.t003
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Within all the dimensions together, 89.3% of the items were selected. A total of 10.7% of the
items remained unused, however, those items all belonged to the largest dimension, namely the
impact dimension, which contained about 10 times more items than either the severity or vari-
ability dimension.
Measurement precision
The measurement precision on the three CAT dimensions turned out as expected (Table 6).
For the dimensions severity and impact, a mean standard error (SE) of 0.14 was found which is
clearly below the criterion of 0.32 for an excellent measurement precision. The mean SE for the
dimension variability was slightly higher than the criterion, with a value of 0.37.
On the CAT dimension severity, 94% of the 166 cases had a SE beneath the criterion of 0.32.
On the dimension impact, 93% of the cases had a SE beneath the criterion of 0.32, and on the
dimension variability only 7%. Nevertheless, with regard to the variability dimension, 90% of
the cases had a SE beneath 0.44, which is comparable to a classical reliability of 0.81.
Table 4. Correlations CAT with BRAF-MDQ, BRAF-NRS and SF-36.
CAT severity CAT impact CAT variability
BRAF physical 0.88 0.81 0.60
BRAF living 0.73 0.71 0.54
BRAF emotion 0.62 0.62 0.39
BRAF cognition 0.65 0.64 0.45
BRAF-NRS severity 0.81 0.76 0.56
BRAF-NRS effect 0.74 0.73 0.54
BRAF-NRS coping -0.30 -0.36 -0.20
SF-36 Physical Functioning (PF) -0.53 -0.55 -0.40
SF-36 Role Physical (RP) -0.60 -0.62 -0.46
SF-36 Bodily Pain (BP) -0.50 -0.53 -0.39
SF-36 General Health (GH) -0.55 -0.51 -0.40
SF-36 Vitality (VT) -0.74 -0.74 -0.50
SF-36 Social Functioning (SF) -0.58 -0.61 -0.42
SF-36 Role Emotional (RE) -0.53 -0.56 -0.35
SF-36 Mental Health (MH) -0.51 -0.54 -0.34
Number of confirmed hypotheses 13 out of 15 13 out of 15 8 out of 15
Percentage confirmed hypotheses 87% 87% 53%
Bold numbers indicate that the correlation is in line with our hypotheses.
doi:10.1371/journal.pone.0145008.t004
Table 5. Frequency of item usage per CAT dimension in 166 CAT administrations.
Severity (13 items) Impact (169 items) Variability (14 items)
Item not used - 21 (12.4%) -
 25 times 1 (7.7%) 131 (77.5%) 4 (28.6%)
26–50 times 4 (30.1%) 7 (4.1%) 5 (35.7%)
51–100 times 6 (46.2%) 8 (4.7%) 2 (14.3%)
101–125 times 2 (15.4%) 2 (1.2%) -
126–150 - - 1 (7.1%)
> 150 - - 2 (14.3%)
doi:10.1371/journal.pone.0145008.t005
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Score distribution
The fatigue scores (theta-values) on the three CAT dimensions were mainly concentrated
around the value of zero (S1–S3 Figs). There were no floor- or ceiling-effects. Clearly, less than
15% of the scores were located above the value of 2 or below the value of -2 (Table 2).
Discussion
Our results showed that, overall, the multidimensional CAT Fatigue RA has good measure-
ment characteristics. Construct validity was supported for the CAT dimensions severity and
impact with most of their examined associations with the BRAF-MDQ, BRAF-NRS and SF-36
achieving results as expected. The construct validity of the CAT dimension variability was less
convincing. This result is in line with our previous finding [18] that this dimension has a less
ideal model fit than the other two dimensions. We included the variability dimension in the
CAT Fatigue RA because it reflects aspects that were brought up by patients [3–6] and it was
part of the best fitting IRT model in our calibration study [18]. However, variability of fatigue
seems to be more difficult to measure than severity and impact. The challenge is that fewer
options can be asked about the variability of fatigue than about severity and impact, which
complicates the development of accurate items that measure on different locations of the
fatigue continuum. The Multidimensional Assessment of Fatigue [MAF] [41] is one of the few
fatigue questionnaires that includes the aspect of changes in fatigue. Remarkably, a change in
fatigue is covered by one single item that is not used for the calculation of the global fatigue
score. To conclude, the variability dimension should not be applied in daily clinical practice or
research without further examination. A logical next step is the recalibration of the CAT item
bank with a two-dimensional model.
Our results reflected a very good usage of the item pool. Most of the items in the pool were
selected in the 166 CAT administrations. Only some items of the impact dimension remained
unused, which is not surprising since it contains about ten times more items than the severity
and variability dimensions. Moreover, the CAT always administered at least five items per
dimension so that a maximum of ten impact items would be administered per patient. It could
be considered to leave the unused items out of the recalibration in order to streamline the item
pool.
Measurement precision of the CAT was excellent for the dimensions severity and impact.
Although the dimension variability had not such an excellent measurement precision, it
showed a satisfactory precision in most cases.
The distribution of the fatigue scores showed no floor- and ceiling-effects. It is the charac-
teristic of a well-functioning CAT that items are matched to the individual level of a patient.
However, in order to achieve such matching, enough adequate items at the extremes of the
Table 6. Standard errors per CAT dimension (N = 166).
CAT severity CAT impact CAT variability
Mean SE 0.14 0.14 0.37
Standard deviation 0.08 0.09 0.06
Minimum 0.06 0.06 0.28
Maximum 0.43 0.47 0.61
Percentiles
25 0.09 0.09 0.34
50 0.12 0.11 0.35
75 0.16 0.15 0.38
doi:10.1371/journal.pone.0145008.t006
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underlying dimension have to be available from the item bank. Only minimal floor- and ceiling
effects have also been found in other multidimensional CATs [24, 25]. We did not examine
floor- and ceiling-effects by calculating the number of participants that responded to each item
in the CAT with the highest or the lowest possible score. This is due to the fact that each patient
received a different selection of twenty out of 196 possible items. In addition, the items in the
item bank differ regarding the kind and number of their response options.
Four items of the SF-36 (subscale vitality) and 19 of the 20 BRAF items were part of our
CAT item bank [16]. This might be a limitation of the analyses regarding construct validity,
leading to superficially high correlations. However, those items only form a small part of the
whole item bank (11.7%) and not all of them were selected for each CAT administration. Fur-
thermore, we also used seven subscales of the SF-36 whose items are not part of the CAT item
pool for validation purposes. In addition, the strength of the correlations found for the CAT
dimensions and the other fatigue measures were comparable to those found in the evaluation
study of the BRAF-MDQ [10].
Another remark concerns the BRAF-NRS coping scale. Dures et al. [32] concluded that cop-
ing with fatigue is a construct separate from severity and other dimensions, hence we expected
a moderate and not a high correlation with the CAT. However, the correlations with the CAT
severity and variability were low. Only the correlation with the CAT impact dimension was
moderate which might be related to a small proportion of items about coping with fatigue
(6.5% of 169) that are part of this dimension. Possible explanations for the low correlations are
the adequate but not strong reliability of the NRS, or confusion by patients regarding high/low
scores. High scores represented a positive outcome (good coping) while high scores on the
NRS severity and effect indicated a negative outcome [32].
Moreover, it is difficult to compare the measurement precision of the CAT Fatigue RA with
those of the BRAF-MDQ or other traditional fatigue questionnaires. For the evaluation of the
standard errors on the CAT dimensions, we applied the criterion of 0.32 which corresponds to
a classical reliability of Cronbachs alpha = 0.90. It is not possible to simply compare this crite-
rion to the internal consistency of a unidimensional scale because the concepts of reliability are
different. The CAT Fatigue RA is measuring in a three-dimensional space in form of an ellipse,
meaning that the decline of the standard errors on the dimensions during the CAT administra-
tion can develop in a non-monotone way [38].
A recent study about the measurement of fatigue in RA showed that BRAF-MDQ, the
BRAF-NRS and the subscale vitality of the SF-36 differ in their measurement precision along the
fatigue continuum [42]. For example, the SF-36 is better suited to measure fatigue in patients
with relatively low levels of fatigue while the BRAF-MDQ is the better choice for patients with
higher levels of fatigue. Also another study [43] showed that the suitability of a measurement
instrument depends on the sample in which it is used. For patients with RA and low levels of dis-
ease activity and low levels of fatigue, the items of one dimension might be most adequate. On
the other hand, for patients with higher levels of fatigue, one or more additional dimensions
might provide the best measurement result [43]. Our CAT contains items of different question-
naires and measures in a multidimensional way. By enabling the selection of the best suited items
for the measurement of a patient’s individual fatigue level, our CAT, therefore, provides an
important advantage. Furthermore, a multidimensional measurement instrument provides
insight into different experiences of fatigue since it is possible to see individual compositions of
scores. For example, some patients might score higher on impact, others on severity [38].
The results of this study were obtained within an outpatient sample with a relative long dis-
ease duration with a broad range. It would be interesting to test the CAT’s measurement prop-
erties in different samples of patients with RA, for example categorized by different disease
durations, or by other disease characteristics.
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The use of multidimensional CATs based on multidimensional IRT is a relatively recent
development in health care, and clear guidelines for their design and evaluation are lacking
[23]. General guidelines for the evaluation of the quality of a health-related PRO measure rec-
ommend the examination of reliability (e.g. internal consistency, test-retest reliability and mea-
surement error), validity (content validity, criterion validity and construct validity),
responsiveness and interpretability [27, 28]. Reliability of the CAT Fatigue RA was examined
by means of measurement error.
Examination of other PRO measurement characteristics to evaluate the quality of our CAT
Fatigue RA were considered as follows. Internal consistency refers to the correlations between
different items on the same measurement instrument. For a CAT, no internal consistency in
the traditional sense can be calculated because each participant receives different combinations
of items. Content validity was extensively examined previously [6, 9, 15–17]. Criterion validity
refers to the correlation with a gold standard [11], which is not available for the measurement
of fatigue in RA [44], so that the validity of the CAT Fatigue RA was examined by means of
construct validity. Interpretability was examined by means of item usage and score
distribution.
Further quality standards indicate that PRO measures should be based on a conceptual and
measurement model, that the patient and investigator burden is adequate and that the proce-
dure of possible translations and their evaluation are well-documented [28]. The CAT Fatigue
RA fulfils these standards. Its development started with research aiming to understand the con-
cept of fatigue in the RA population. Consequently, items and dimensions were extensively
studied and documented by incorporating expert opinions and advanced statistical methods.
In fact, the concept of CAT facilitates a reduced burden for patients and investigators com-
pared to traditional questionnaires, and the usability of the CAT Fatigue RA has been demon-
strated in a previous study [30]. Translated versions are not yet available, and this is subject for
future research. Finally, it has to be mentioned that the use of CAT is dependent on the avail-
ability of appropriate technical facilities and that not every patient is able or willing to fill in an
online questionnaire. Consequently, using CAT in fatigue measurement might imply the risk
of selection bias. However, the availability of internet access in the Netherlands is high. With a
coverage ratio of internet access of 97% in general in the Netherlands and 80% in the age group
of 65–75 years using internet, the reach is relatively well secured [45, 46].
This study has shown that the CAT Fatigue RA measures fatigue very precisely on different
dimensions at an individual level while using a large amount of different items. The CAT
Fatigue RA is a promising measurement instrument because of its unique advantage of
enabling the selection of the best suited items for the measurement of a patient’s individual
fatigue level along with this study’s positive findings regarding its usability [30]. Future
research should investigate whether the dimension variability has to be omitted from the CAT
item pool. Afterwards, its measurement properties regarding test-retest reliability, discrimina-
tive validity and responsiveness should be assessed.
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